Homebiotech

biotech

biotech

Positive topline results from phase 2 recurrent ovarian cancer trial

Jim Cornall - May 26, 2026

biotech

Rare oral cancer has distinct genetic profile

Jim Cornall - May 26, 2026

biotech

New tool decodes structures and motifs of RNA

Jim Cornall - May 26, 2026

biotech

Elite immune cells lead fight against multiple myeloma

Jim Cornall - May 25, 2026

biotech

Naobios and SGS partner to manufacture RSV challenge agent

Jim Cornall - March 9, 2026

biotech

New approach to drug development

Jim Cornall - March 9, 2026

AI

Base to Base biotech podcast 49: Gene therapy for kidney disease, and using AI to transform diagnostics

Jim Cornall - March 6, 2026

biotech

Antifibrotic drug shows promise for premature ovarian insufficiency

Jim Cornall - March 5, 2026

biotech

Immune cells remember their location

Jim Cornall - March 5, 2026

biotech

HPV vaccine provides long-term protection against cervical cancer

Jim Cornall - March 5, 2026

biotech

First in-utero stem cell therapy for foetal spina bifida repair is safe, study finds

Jim Cornall - March 4, 2026

biotech

First medicine for allergic fungal rhinosinusitis gets US approval

Jim Cornall - March 4, 2026

1...171819...78 Page 18 of 78

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Positive topline results from phase 2 recurrent ovarian cancer trial

Jim Cornall - May 26, 2026 0

OSE Immunotherapeutics SA has announced the release of the abstract selected for an oral presentation at the upcoming ASCO 2026 annual meeting, unveiling topline...

Rare oral cancer has distinct genetic profile

biotech Jim Cornall - May 26, 2026 0

New tool decodes structures and motifs of RNA

biotech Jim Cornall - May 26, 2026 0

Elite immune cells lead fight against multiple myeloma

biotech Jim Cornall - May 25, 2026 0

National framework to strengthen UK advanced therapy clinical trials

biotech Jim Cornall - May 25, 2026 0